1. An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice—The MS‐MRIUS Study. Issue 3 (5th December 2016) Authors: Zivadinov, Robert; Khan, Nasreen; Medin, Jennie; Christoffersen, Pia; Price, Jennifer; Korn, Jonathan R.; Bonzani, Ian; Dwyer, Michael G.; Bergsland, Niels; Carl, Ellen; Silva, Diego; Weinstock‐Guttman, Bianca Journal: Journal of neuroimaging Issue: Volume 27:Issue 3(2017) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis. (December 2013) Authors: Bergvall, Niklas; Makin, Charles; Lahoz, Raquel; Agashivala, Neetu; Pradhan, Ashish; Capkun, Gorana; Petrilla, Allison; Karkare, Swapna U.; Balderston McGuiness, Catherine; Korn, Jonathan R. Journal: Current medical research and opinion Issue: Volume 29:Number 12(2013:Dec.) Page Start: 1647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis. (May 2015) Authors: Capkun, Gorana; Lahoz, Raquel; Verdun, Elisabetta; Song, Xue; Chen, Weston; Korn, Jonathan R.; Dahlke, Frank; Freitas, Rita; Fraeman, Kathy; Simeone, Jason; Johnson, Barbara H.; Nordstrom, Beth Journal: Current medical research and opinion Issue: Volume 31:Number 5(2015:May) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS‐MRIUS. Issue 4 (11th May 2018) Authors: Zivadinov, Robert; Medin, Jennie; Khan, Nasreen; Korn, Jonathan R.; Bergsland, Niels; Dwyer, Michael G.; Chitnis, Tanuja; Naismith, Robert T.; Alvarez, Enrique; Kinkel, Peter; Cohan, Stanley; Hunter, Samuel F.; Silva, Diego; Weinstock‐Guttman, Bianca Journal: Journal of neuroimaging Issue: Volume 28:Issue 4(2018) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis. (August 2014) Authors: Bergvall, Niklas; Lahoz, Raquel; Reynolds, Tracy; Korn, Jonathan R. Journal: Current medical research and opinion Issue: Volume 30:Number 8(2014:Aug.) Page Start: 1461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study. (3rd August 2018) Authors: Zivadinov, Robert; Khan, Nasreen; Korn, Jonathan R.; Lathi, Ellen; Silversteen, Jason; Calkwood, Jonathan; Kolodny, Scott; Silva, Diego; Medin, Jennie; Weinstock-Guttman, Bianca Journal: Current medical research and opinion Issue: Volume 34:Number 8(2018) Page Start: 1431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis. (October 2014) Authors: Bergvall, Niklas; Petrilla, Allison A.; Karkare, Swapna U.; Lahoz, Raquel; Agashivala, Neetu; Pradhan, Ashish; Capkun, Gorana; Makin, Charles; McGuiness, Catherine Balderston; Korn, Jonathan R. Journal: Journal of medical economics Issue: Volume 17:Number 10(2014) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis. (August 2014) Authors: Curtis, Jeffrey R.; Schabert, Vernon F.; Yeaw, Jason; Korn, Jonathan R.; Quach, Caroleen; Harrison, David J.; Yun, Huifeng; Joseph, George J.; Collier, David Journal: Journal of medical economics Issue: Volume 17:Number 8(2014) Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗